Hidradenitis Suppurativa and Celiac Disease Association
Based on the most comprehensive and recent guideline evidence, celiac disease is NOT specifically identified as a recognized comorbidity requiring screening in hidradenitis suppurativa (HS). The 2022 US and Canadian HS Foundations evidence-based comorbidity screening guidelines do not include celiac disease among the recommended conditions to screen for in HS patients 1.
What the Evidence Shows
The most authoritative guidelines from 2022 and 2024 systematically reviewed 30 potential comorbidities associated with HS and provided specific screening recommendations 1. Celiac disease was not among the conditions that met criteria for screening recommendation, despite the comprehensive nature of these reviews.
Recognized HS Comorbidities Include:
The evidence-based screening recommendations focus on:
- Gastrointestinal: Inflammatory bowel disease (Crohn's disease and ulcerative colitis) - with approximately 2% prevalence and 3-fold increased risk 2
- Metabolic: Obesity, diabetes mellitus, dyslipidemia, metabolic syndrome, hypertension
- Dermatologic: Acne, dissecting cellulitis of the scalp, pilonidal disease, pyoderma gangrenosum
- Psychiatric: Depression, generalized anxiety disorder, substance use disorders
- Other systemic: Cardiovascular disease, spondyloarthritis, polycystic ovary syndrome
Limited Research Mention
One large-scale epidemiological study from 2023 examining comorbidities across multiple skin diseases noted that celiac disease showed strong associations with various skin conditions generally 3. However, this study did not specifically highlight or quantify a clinically significant association between celiac disease and HS that would warrant screening recommendations.
Clinical Implications
Do not routinely screen HS patients for celiac disease unless they present with specific gastrointestinal symptoms (chronic diarrhea, malabsorption, unexplained weight loss) or other clinical indicators that would warrant celiac screening independent of their HS diagnosis.
Important Caveat
While inflammatory bowel disease (particularly Crohn's disease) IS strongly associated with HS and requires screening 2, 1, this should not be confused with celiac disease. Both are gastrointestinal inflammatory conditions, but they are distinct entities with different pathophysiology.
Focus Your Screening Efforts On:
The evidence strongly supports screening for inflammatory bowel disease in HS patients, given the shared inflammatory pathways, cytokine profiles, and response to TNF inhibitors 2. This represents a true disease association with clinical management implications, unlike celiac disease which lacks such evidence in the HS population.